Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03823404
Recruitment Status : Completed
First Posted : January 30, 2019
Last Update Posted : March 9, 2022
Information provided by (Responsible Party):
Cortexyme Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 1, 2022
Actual Study Completion Date : January 1, 2022